Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 8, Pages 1150
Publisher
MDPI AG
Online
2019-08-12
DOI
10.3390/cancers11081150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers
- (2019) Ibrahim Halil Erdogdu Gastroenterology Research and Practice
- CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy
- (2018) Qi-Feng He et al. Briefings in Functional Genomics
- Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer
- (2018) Dan Tan et al. Cancer Biomarkers
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Unknown
- (2018) Experimental and Clinical Transplantation
- Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population
- (2018) Qigui Xie et al. GENE
- PD-1/PD-L1 in disease
- (2018) Nyanbol Kuol et al. Immunotherapy
- PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
- (2018) Bingxin Zheng et al. Journal of Hematology & Oncology
- Inhibitors of the PD-1 Pathway in Tumor Therapy
- (2018) Martin W. LaFleur et al. JOURNAL OF IMMUNOLOGY
- Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy
- (2018) Davis A. Witt et al. PEDIATRIC BLOOD & CANCER
- Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer
- (2018) Calogerina Catalano et al. PLoS One
- Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
- (2018) Jonna Berntsson et al. OncoImmunology
- H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cells
- (2018) Priscilla S. Redd et al. OncoImmunology
- Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience
- (2018) Mohammed Salhab et al. Journal for ImmunoTherapy of Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta-analysis
- (2018) Mohammad Hashemi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Association between miR-34b/c rs4938723 polymorphism and risk of cancer: An updated meta-analysis of 27 case-control studies
- (2018) Mohammad Hashemi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis
- (2018) Liang-Shan Da et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma
- (2018) Kosuke Ueda et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- High expression of programmed cell death protein 1 on peripheral blood T‑cell subsets is associated with poor prognosis in metastatic gastric cancer
- (2018) Bian Shi et al. Oncology Letters
- PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck
- (2018) Farshid Fathi et al. IMMUNOLOGICAL INVESTIGATIONS
- Association between CASP3 polymorphisms and overall cancer risk: A meta-analysis of case-control studies
- (2018) Mohammad Hashemi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer
- (2018) Yanhua Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration
- (2018) Dan Yu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis
- (2018) Ju Zou et al. PATHOLOGY RESEARCH AND PRACTICE
- Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration
- (2018) Yoong Wearn Lim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effect of polymorphisms in PD-1 gene on the risk of epithelial ovarian cancer and patients' outcomes
- (2017) Yan Li et al. GYNECOLOGIC ONCOLOGY
- Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
- (2017) Min-Kyung Yeo et al. HUMAN PATHOLOGY
- PD-1 and cancer: molecular mechanisms and polymorphisms
- (2017) Arash Salmaninejad et al. IMMUNOGENETICS
- Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients
- (2017) Fatemeh Namavar Jahromi et al. IMMUNOLOGICAL INVESTIGATIONS
- Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
- (2017) Gerardo Botti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination
- (2017) Arash Memarnejadian et al. JOURNAL OF IMMUNOLOGY
- PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease
- (2017) Kathryn W. Juchem et al. JOURNAL OF IMMUNOLOGY
- Variant SNPs at the microRNA complementary site in the B7-H1 3′-untranslated region increase the risk of non-small cell lung cancer
- (2017) Wenwen Du et al. Molecular Medicine Reports
- Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
- (2017) Jinfang Zhang et al. NATURE
- PDCD1 gene polymorphisms as regulators of T-lymphocyte activity in cutaneous melanoma risk and prognosis
- (2017) Gabriela V. B. Gomez et al. Pigment Cell & Melanoma Research
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract
- (2017) Michael Dougan Frontiers in Immunology
- A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer
- (2016) Li-Hua Tao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Association of the programmed cell death-1 PD1.5 C>T polymorphism with cervical cancer risk in a Chinese population
- (2016) X.F. Li et al. GENETICS AND MOLECULAR RESEARCH
- PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women
- (2016) Hong-Tao Ren et al. MEDICINE
- The association between polymorphisms in the PDCD1 gene and the risk of cancer
- (2016) Jie Zhang et al. MEDICINE
- Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
- (2016) Wenjing Dong et al. PLoS One
- Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma
- (2016) Rong-Miao Zhou et al. Cancer Genetics
- Association of PDCD1 gene markers with susceptibility to thyroid cancer
- (2016) M. R. Haghshenas et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese
- (2015) Jie Ge et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Adaptive Immune Resistance: How Cancer Protects from Immune Attack
- (2015) A. Ribas Cancer Discovery
- Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer
- (2014) Hao Qiu et al. CLINICAL BIOCHEMISTRY
- A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma
- (2013) Weipeng Wang et al. HUMAN GENETICS
- Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
- (2013) Zhu Li et al. INFECTION GENETICS AND EVOLUTION
- Association between single nucleotide polymorphism ofPD-L1gene and non-small cell lung cancer susceptibility in a Chinese population
- (2012) Yan-bin Chen et al. Asia-Pacific Journal of Clinical Oncology
- Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: A case–control study
- (2012) Süleyman Bayram et al. GENE
- Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer
- (2012) Zahra Mojtahedi et al. GENE
- Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
- (2012) N. Patsoukis et al. Science Signaling
- PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China
- (2011) Zhang Hua et al. BREAST CANCER RESEARCH AND TREATMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genome-Wide Association Studies of Cancer
- (2010) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- Program death 1 (PD1) haplotyping in patients with breast carcinoma
- (2010) Mohammad Reza Haghshenas et al. MOLECULAR BIOLOGY REPORTS
- Management of Gene Promoter Mutations in Molecular Diagnostics
- (2009) K. M. K. de Vooght et al. CLINICAL CHEMISTRY
- Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer
- (2009) Emma L. Ivansson et al. GYNECOLOGIC ONCOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started